B-Cell Maturation Antigen (Bcma) Anti-Idiotypic Antibodies - EP4590708
The patent EP4590708 was granted to Pfizer on Jul 30, 2025. The application was originally filed on Sep 18, 2023. The patent is currently recorded with a legal status of "Pending".
EP4590708
- Filing Date
- Sep 18, 2023
- Status
- Pending
- Grant Date
- Jul 30, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents